Thyrocare Technologies Limited (THYROCARE.BO)

INR 980.85

(-1.19%)

Market Cap (In INR)

51.95 Billion

Revenue (In INR)

5.71 Billion

Net Income (In INR)

707.6 Million

Avg. Volume

17.66 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
555.85-1050.65
PE
-
EPS
-
Beta Value
0.441
ISIN
INE594H01019
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Rahul Franklin Guha
Employee Count
-
Website
https://www.thyrocare.com
Ipo Date
Details
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

More Stocks